Covid-19 vaccine trial: principal investigator explains how it works


Kaiser Permanente is participating in a phase 3 clinical trial to test a vaccine against covid-19. It will include approximately 1,400 participants at 4 sites in California and Oregon, and 30,00 worldwide.

Dr. Nicola Klein, director of the Kaiser Permanente Vaccine Study Center and principal investigator for the trial in Northern California explained the details of the trial to KSEE24’s Stefani Booroojian.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

CBS47 On Your Side

Do you have a problem that you need help solving? Contact CBS47 and let us be On Your Side.

Phone: 559-761-0383